Dr. Peggy Rechthand Lazerow

M.D. | Neurology


  5051 Greenspring Ave, Baltimore
     Maryland, 21209-4354
  410-601-8300    410-601-8227 Maps & Directions
Dr. Peggy Rechthand Lazerow is a Baltimore, Maryland based neurologist who is specialized in Neurology. Her current practice location is 5051 Greenspring Ave, Baltimore. Patients can reach her at 410-601-8300 or can fax her at 410-601-8227. Dr. Peggy Rechthand Lazerow is M.D. in Neurology and her NPI number (Unique professional ID assigned by NPPES) is 1063706752.
Dr. Peggy Rechthand Lazerow specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Peggy Rechthand Lazerow speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Peggy Rechthand Lazerow
Specialization: Neurology
Gender:Female
Credentials: M.D.
Practice Address:5051 Greenspring Ave, Baltimore,
Maryland, 21209-4354
Phone:410-601-8300
Fax:410-601-8227
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1063706752
NPI Enumeration Date: 31 May, 2011
NPI Last Update On: 08 Mar, 2022

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Peggy Rechthand Lazerow
2401 W Belvedere Ave,
Baltimore, Maryland
Zip: 21215-5216
Patients can reach Dr. Peggy Rechthand Lazerow at 5051 Greenspring Ave, Baltimore, Maryland or can call to book an appointment on 410-601-8300.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.